Home | About the eMC | Help | Mobile
eMC - trusted, up to date and comprehensive information about medicines
Link to eMC medicine guides website
eMC homepage
Advanced search
Get Medicines Compendium UK app here

AstraZeneca UK Limited
Horizon Place, 600 Capability Green, Luton, Bedfordshire, LU1 3LU
Telephone: +44 (0)1582 836 000
Fax: +44 (0)1582 838 000
Medical Information Direct Line: +44 (0)1582 836 836
Medical Information e-mail: medical.informationuk@astrazeneca.com
Customer Care direct line: +44 (0)1582 837 837
Medical Information Fax: +44 (0)1582 838 003

Before you contact this company: often several companies will market medicines with the same active ingredient. Please check that this is the correct company before contacting them. Why?
Patient Information Leaflet last updated on the eMC: 02/05/2012
PIL Crestor 5mg, 10mg, 20mg and 40mg film-coated tablets

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 02/05/2012 and displayed until Current
Reasons for adding or updating:
  • Change to side-effects
  • Change to warnings or special precautions for use
  • Change to date of revision
Updated on 22/12/2011 and displayed until 02/05/2012
Reasons for adding or updating:
  • Change to date of revision
  • Change to side-effects
  • Removal of Black Triangle
Updated on 28/09/2010 and displayed until 22/12/2011
Reasons for adding or updating:
  • Change of manufacturer
Updated on 15/06/2010 and displayed until 28/09/2010
Reasons for adding or updating:
  • Change of manufacturer
Updated on 07/05/2010 and displayed until 15/06/2010
Reasons for adding or updating:
  • Change to, or new, use for medicine
  • Change to warnings or special precautions for use
  • Change to side-effects
  • Change to manufacturer contact details
Updated on 06/05/2010 and displayed until 07/05/2010
Reasons for adding or updating:
  • Change to, or new, use for medicine
  • Change to warnings or special precautions for use
  • Change to side-effects
  • Change to manufacturer contact details
  • PIL Retired pending re-submission
Updated on 07/05/2009 and displayed until 06/05/2010
Reasons for adding or updating:
  • Change to appearance of the medicine
Updated on 11/08/2008 and displayed until 07/05/2009
Reasons for adding or updating:
  • Change to side-effects
Updated on 01/04/2008 and displayed until 11/08/2008
Reasons for adding or updating:
  • Transfer to upgraded management system
Updated on 12/02/2008 and displayed until 01/04/2008
Reasons for adding or updating:
  • Change of inactive ingredient
  • Change to side-effects
Updated on 25/10/2007 and displayed until 12/02/2008
Reasons for adding or updating:
  • Change to warnings or special precautions for use
  • Change to storage instructions
  • Change to side-effects
Updated on 22/01/2007 and displayed until 25/10/2007
Reasons for adding or updating:
  • Change due to harmonisation of patient information leaflet
Updated on 08/05/2006 and displayed until 22/01/2007
Reasons for adding or updating:
  • Change to warnings or special precautions for use
  • Change to side-effects
  • Change to drug interactions
  • Change to date of revision
Updated on 02/11/2005 and displayed until 08/05/2006
Reasons for adding or updating:
  • Change to dosage and administration
  • Introduction of new strength
Updated on 15/06/2005 and displayed until 02/11/2005
Reasons for adding or updating:
  • Change to side-effects
  • Change to date of revision
Updated on 14/01/2005 and displayed until 15/06/2005
Reasons for adding or updating:
  • Change to side-effects
Updated on 09/06/2004 and displayed until 14/01/2005
Reasons for adding or updating:
  • Correction of spelling/typing errors
Updated on 09/06/2004 and displayed until 09/06/2004
Reasons for adding or updating:
  • Change to warnings or special precautions for use
  • Change of contra-indications
  • Change to side-effects
  • Change to drug interactions
  • Change to date of revision
  • Change to how to administer the medicine
Updated on 17/03/2004 and displayed until 09/06/2004
Reasons for adding or updating:
  • Improved Electronic Presentation
Updated on 31/03/2003 and displayed until 17/03/2004
Reasons for adding or updating:
  • New PIL for new product

Active Ingredients/Generics

 
  rosuvastatin calcium